Works by Schumacher, Karl


Results: 17
    1
    2
    3
    4
    5

    A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.

    Published in:
    Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1646-4
    By:
    • Cohen, Stanley B.;
    • Alten, Rieke;
    • Kameda, Hideto;
    • Hala, Tomas;
    • Radominski, Sebastiao C.;
    • Rehman, Muhammad I.;
    • Palaparthy, Ramesh;
    • Schumacher, Karl;
    • Schmitt, Susanne;
    • Hua, Steven Y.;
    • Ianos, Claudia;
    • Lea Sewell, K.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072
    By:
    • Sakai, Hiroshi;
    • Morise, Masahiro;
    • Kato, Terufumi;
    • Matsumoto, Shingo;
    • Sakamoto, Tomohiro;
    • Kumagai, Toru;
    • Tokito, Takaaki;
    • Atagi, Shinji;
    • Kozuki, Toshiyuki;
    • Tanaka, Hiroshi;
    • Chikamori, Kenichi;
    • Shinagawa, Naofumi;
    • Takeoka, Hiroaki;
    • Bruns, Rolf;
    • Straub, Josef;
    • Schumacher, Karl Maria;
    • Paik, Paul K
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17